Obesity Researcher Honored With Scientific Achievement Award
CINCINNATIRandy Seeley, PhD, University of Cincinnati (UC) professor of psychiatry and associate director of the Obesity Research Center, has been given the Outstanding Scientific Achievement Award by the American Diabetes Association (ADA).
The award recognizes outstanding scientific achievement in the field of diabetes, taking into consideration independence of thought and originality, and is being presented this week at the ADAs 69th Annual Scientific Sessions in New Orleans.
Seeleys work is focused on peripheral hormones in the central nervous system that regulate food intake and body weight. In particular, he has focused on the numerous hypothalamic and gastrointestinal peptides and their associated receptors that influence both energy intake and energy expenditure.
He leads a partnership with Cincinnatis Ethicon Endo-Surgery aimed at better understanding of the basic biology behind obesity and finding new solutions for treating obesity and related conditions, including diabetes. The main focus of this research is to gain insight into the hows and whys behind bariatric surgerysuch as the Roux-en-Y gastric bypass procedure.
Seeley is the Donald C. Harrison Endowed Chair and past winner of the Lilly Scientific Achievement Award (2003) and the Ernst Oppenheimer Award from the Endocrine Society (2008). In 2006 he was invited to present at the Nobel Symposium.
Randy Seeley, PhD, director of the Cincinnati Diabetes and Obesity Center.
Obesity researcher Randy Seeley, PhD
Obesity researcher Randy Seeley, PhD
Randy Seeley, PhD, director of the Cincinnati Diabetes and Obesity Center.
Tags
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.